Product Description
Since last manyA years Saintroy Lifescience is leading manufacture, export andsupplier ofA Cefpodoxime and ClavulanateA Oral Suspension from Surat, Gujarat, India. Cefpodoxime And Clavulanate Oral Suspension used treatment for many types of infections,including sinus infections, and urinary tract infections, including pyelonephritis.
Tags: Cefpodoxime and Clavulanic Oral Suspension manufacturer, Cefpodoxime AndA ClavulanateA Oral Suspension exporter, Cefpodoxime and Clavulanic Oral SuspensionA supplier, and Cefpodoxime and Clavulanic Oral Suspension, whogmp approved CefpodoximeA and ClavulanateA Oral Suspension manufacturer and supplier, Cefpodoxime AndA Clavulanic Oral Suspension distributor, Cefpodoxime and Clavulanic Oral SuspensionA shipper, Cefpodoxime and ClavulanateA Oral Suspension 30 ml Cefpodoxime AndA Clavulanic Oral Suspension 30 ml supplier, Cefpodoxime and Clavulanate OralA Suspension 30 ml.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facilityin Gujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health ofclients country and we also provide the products samples, COA, COPP, ACTD or CTDossier, DMF, Manufacturing license, Free sales certificate and other requireddocuments.
Export Country :Saintroy Lifescience Cefpodoxime andClavulanic Oral Suspension export to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
Powerful Antibiotic for ChildrenCefpodoxime and Clavulanic Oral Suspension offers robust protection against bacterial infections in children. The dual ingredient formula combats resistant bacteria, providing effective relief when prescribed by a medical professional. Always use this medicine under medical supervision to ensure safe dosage and maximized benefit.
Trusted Distribution and Supply NetworkThis suspension is manufactured, exported, and supplied by reputable channels throughout India. Dealers, distributors, traders, and wholesalers collaborate to ensure the medicine's availability to healthcare providers nationwide. The supply chain ensures the product's reliability and quality from manufacture to end use.
FAQ's of Cefpodoxime and Clavulanic Oral Suspension:
Q: How should Cefpodoxime and Clavulanic Oral Suspension be administered to children?
A: This oral suspension should only be given according to the dosage instructions provided by the child's doctor or physician. It is typically measured with a medical dosing device for accuracy.
Q: What are the main benefits of using this antibiotic suspension?
A: The combination of Cefpodoxime and Clavulanic Acid broadens the spectrum of antibacterial action, effectively treating various pediatric infections resistant to standard antibiotics.
Q: When is this medicine recommended for children?
A: Doctors prescribe this medicine for children suffering from bacterial infections that require an oral antibiotic, especially when conventional treatments may not be effective.
Q: Where should I store Cefpodoxime and Clavulanic Oral Suspension?
A: To maintain its efficacy, store the suspension in a cool, dry place away from direct sunlight and heat, as indicated in the product's storage instructions.
Q: What is the process for obtaining this medicine in India?
A: You can acquire this oral suspension through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers located throughout India, often via a doctor's prescription.
Q: How does the combination of these ingredients improve treatment?
A: Clavulanic Acid helps prevent bacterial resistance to Cefpodoxime, thus enhancing the medicine's effectiveness against tough bacterial pathogens.